nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—Acute lymphocytic leukaemia—Pamidronate—Paget's disease of bone	0.0406	0.0871	CcSEcCtD
Bosutinib—Rash macular—Etidronic acid—Paget's disease of bone	0.0127	0.0272	CcSEcCtD
Bosutinib—Abdominal pain lower—Risedronate—Paget's disease of bone	0.0112	0.024	CcSEcCtD
Bosutinib—Abdominal pain lower—Zoledronate—Paget's disease of bone	0.00972	0.0209	CcSEcCtD
Bosutinib—Rash generalised—Risedronate—Paget's disease of bone	0.00837	0.018	CcSEcCtD
Bosutinib—Rash macular—Zoledronate—Paget's disease of bone	0.00753	0.0162	CcSEcCtD
Bosutinib—Hypophosphataemia—Pamidronate—Paget's disease of bone	0.00582	0.0125	CcSEcCtD
Bosutinib—Hypophosphataemia—Zoledronate—Paget's disease of bone	0.00532	0.0114	CcSEcCtD
Bosutinib—Rash maculo-papular—Etidronic acid—Paget's disease of bone	0.00473	0.0102	CcSEcCtD
Bosutinib—Back pain—Tiludronate—Paget's disease of bone	0.0046	0.00986	CcSEcCtD
Bosutinib—Pleural effusion—Pamidronate—Paget's disease of bone	0.00442	0.00948	CcSEcCtD
Bosutinib—Myalgia—Tiludronate—Paget's disease of bone	0.00404	0.00868	CcSEcCtD
Bosutinib—Arthralgia—Tiludronate—Paget's disease of bone	0.00404	0.00868	CcSEcCtD
Bosutinib—Pleural effusion—Zoledronate—Paget's disease of bone	0.00404	0.00866	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.00353	0.00758	CcSEcCtD
Bosutinib—Gastritis—Etidronic acid—Paget's disease of bone	0.00334	0.00718	CcSEcCtD
Bosutinib—Hyperkalaemia—Pamidronate—Paget's disease of bone	0.00332	0.00713	CcSEcCtD
Bosutinib—Pain—Tiludronate—Paget's disease of bone	0.00332	0.00712	CcSEcCtD
Bosutinib—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00317	0.0068	CcSEcCtD
Bosutinib—Pancytopenia—Etidronic acid—Paget's disease of bone	0.0031	0.00665	CcSEcCtD
Bosutinib—Abdominal pain—Tiludronate—Paget's disease of bone	0.00307	0.00658	CcSEcCtD
Bosutinib—Hyperkalaemia—Zoledronate—Paget's disease of bone	0.00304	0.00651	CcSEcCtD
Bosutinib—Gastritis—Alendronate—Paget's disease of bone	0.00285	0.00611	CcSEcCtD
Bosutinib—Hepatic function abnormal—Pamidronate—Paget's disease of bone	0.00281	0.00603	CcSEcCtD
Bosutinib—Asthenia—Tiludronate—Paget's disease of bone	0.00278	0.00597	CcSEcCtD
Bosutinib—Agranulocytosis—Etidronic acid—Paget's disease of bone	0.00272	0.00583	CcSEcCtD
Bosutinib—Abdominal discomfort—Alendronate—Paget's disease of bone	0.00267	0.00572	CcSEcCtD
Bosutinib—Renal failure acute—Pamidronate—Paget's disease of bone	0.00266	0.00571	CcSEcCtD
Bosutinib—Diarrhoea—Tiludronate—Paget's disease of bone	0.00265	0.00569	CcSEcCtD
Bosutinib—Dizziness—Tiludronate—Paget's disease of bone	0.00256	0.0055	CcSEcCtD
Bosutinib—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.00247	0.0053	CcSEcCtD
Bosutinib—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.00246	0.00527	CcSEcCtD
Bosutinib—Renal failure acute—Zoledronate—Paget's disease of bone	0.00243	0.00521	CcSEcCtD
Bosutinib—Headache—Tiludronate—Paget's disease of bone	0.00243	0.00521	CcSEcCtD
Bosutinib—Abdominal pain upper—Risedronate—Paget's disease of bone	0.00236	0.00506	CcSEcCtD
Bosutinib—Renal impairment—Zoledronate—Paget's disease of bone	0.00236	0.00506	CcSEcCtD
Bosutinib—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00231	0.00496	CcSEcCtD
Bosutinib—Nausea—Tiludronate—Paget's disease of bone	0.0023	0.00494	CcSEcCtD
Bosutinib—Blood creatinine increased—Pamidronate—Paget's disease of bone	0.0023	0.00494	CcSEcCtD
Bosutinib—Gastritis—Risedronate—Paget's disease of bone	0.00229	0.00491	CcSEcCtD
Bosutinib—Influenza—Risedronate—Paget's disease of bone	0.00223	0.00479	CcSEcCtD
Bosutinib—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.0022	0.00471	CcSEcCtD
Bosutinib—Oedema peripheral—Alendronate—Paget's disease of bone	0.00219	0.00471	CcSEcCtD
Bosutinib—Gastritis—Pamidronate—Paget's disease of bone	0.00217	0.00466	CcSEcCtD
Bosutinib—Bronchitis—Risedronate—Paget's disease of bone	0.00215	0.00461	CcSEcCtD
Bosutinib—Abdominal discomfort—Risedronate—Paget's disease of bone	0.00214	0.00459	CcSEcCtD
Bosutinib—Influenza—Pamidronate—Paget's disease of bone	0.00212	0.00455	CcSEcCtD
Bosutinib—Erythema multiforme—Alendronate—Paget's disease of bone	0.00211	0.00452	CcSEcCtD
Bosutinib—Anaemia—Etidronic acid—Paget's disease of bone	0.0021	0.00451	CcSEcCtD
Bosutinib—Blood creatinine increased—Zoledronate—Paget's disease of bone	0.0021	0.00451	CcSEcCtD
Bosutinib—Dehydration—Zoledronate—Paget's disease of bone	0.00209	0.00448	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00208	0.00445	CcSEcCtD
Bosutinib—Abdominal pain upper—Zoledronate—Paget's disease of bone	0.00205	0.0044	CcSEcCtD
Bosutinib—Leukopenia—Etidronic acid—Paget's disease of bone	0.00204	0.00437	CcSEcCtD
Bosutinib—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.00201	0.0043	CcSEcCtD
Bosutinib—Pneumonia—Risedronate—Paget's disease of bone	0.002	0.0043	CcSEcCtD
Bosutinib—Infestation NOS—Risedronate—Paget's disease of bone	0.00199	0.00427	CcSEcCtD
Bosutinib—Infestation—Risedronate—Paget's disease of bone	0.00199	0.00427	CcSEcCtD
Bosutinib—Gastritis—Zoledronate—Paget's disease of bone	0.00199	0.00426	CcSEcCtD
Bosutinib—Neutropenia—Pamidronate—Paget's disease of bone	0.00198	0.00426	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00197	0.00423	CcSEcCtD
Bosutinib—Influenza—Zoledronate—Paget's disease of bone	0.00194	0.00416	CcSEcCtD
Bosutinib—Arthralgia—Etidronic acid—Paget's disease of bone	0.00194	0.00416	CcSEcCtD
Bosutinib—Discomfort—Etidronic acid—Paget's disease of bone	0.00191	0.00411	CcSEcCtD
Bosutinib—Pneumonia—Pamidronate—Paget's disease of bone	0.0019	0.00408	CcSEcCtD
Bosutinib—Dysgeusia—Alendronate—Paget's disease of bone	0.0019	0.00407	CcSEcCtD
Bosutinib—Infestation NOS—Pamidronate—Paget's disease of bone	0.00189	0.00406	CcSEcCtD
Bosutinib—Infestation—Pamidronate—Paget's disease of bone	0.00189	0.00406	CcSEcCtD
Bosutinib—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00188	0.00404	CcSEcCtD
Bosutinib—Renal failure—Pamidronate—Paget's disease of bone	0.00186	0.00399	CcSEcCtD
Bosutinib—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.00186	0.00399	CcSEcCtD
Bosutinib—Infection—Etidronic acid—Paget's disease of bone	0.00184	0.00396	CcSEcCtD
Bosutinib—Pancytopenia—Zoledronate—Paget's disease of bone	0.00184	0.00395	CcSEcCtD
Bosutinib—Neutropenia—Zoledronate—Paget's disease of bone	0.00181	0.00389	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.0018	0.00387	CcSEcCtD
Bosutinib—Ill-defined disorder—Alendronate—Paget's disease of bone	0.0018	0.00386	CcSEcCtD
Bosutinib—Anaemia—Alendronate—Paget's disease of bone	0.00179	0.00385	CcSEcCtD
Bosutinib—Agranulocytosis—Pamidronate—Paget's disease of bone	0.00177	0.00379	CcSEcCtD
Bosutinib—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00176	0.00379	CcSEcCtD
Bosutinib—Oedema peripheral—Risedronate—Paget's disease of bone	0.00176	0.00378	CcSEcCtD
Bosutinib—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00176	0.00377	CcSEcCtD
Bosutinib—Urethral disorder—Risedronate—Paget's disease of bone	0.00175	0.00376	CcSEcCtD
Bosutinib—Malaise—Alendronate—Paget's disease of bone	0.00175	0.00375	CcSEcCtD
Bosutinib—Infestation NOS—Zoledronate—Paget's disease of bone	0.00173	0.00371	CcSEcCtD
Bosutinib—Infestation—Zoledronate—Paget's disease of bone	0.00173	0.00371	CcSEcCtD
Bosutinib—Renal failure—Zoledronate—Paget's disease of bone	0.0017	0.00365	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00169	0.00363	CcSEcCtD
Bosutinib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00168	0.0036	CcSEcCtD
Bosutinib—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00167	0.00358	CcSEcCtD
Bosutinib—Tinnitus—Risedronate—Paget's disease of bone	0.00167	0.00358	CcSEcCtD
Bosutinib—Urethral disorder—Pamidronate—Paget's disease of bone	0.00167	0.00357	CcSEcCtD
Bosutinib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00166	0.00356	CcSEcCtD
Bosutinib—Chest pain—Alendronate—Paget's disease of bone	0.00165	0.00354	CcSEcCtD
Bosutinib—Myalgia—Alendronate—Paget's disease of bone	0.00165	0.00354	CcSEcCtD
Bosutinib—Discomfort—Alendronate—Paget's disease of bone	0.00163	0.0035	CcSEcCtD
Bosutinib—Immune system disorder—Risedronate—Paget's disease of bone	0.00161	0.00346	CcSEcCtD
Bosutinib—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00161	0.00346	CcSEcCtD
Bosutinib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00161	0.00346	CcSEcCtD
Bosutinib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00158	0.00338	CcSEcCtD
Bosutinib—Infection—Alendronate—Paget's disease of bone	0.00157	0.00337	CcSEcCtD
Bosutinib—Malnutrition—Risedronate—Paget's disease of bone	0.00156	0.00334	CcSEcCtD
Bosutinib—Immune system disorder—Pamidronate—Paget's disease of bone	0.00153	0.00329	CcSEcCtD
Bosutinib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00153	0.00329	CcSEcCtD
Bosutinib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00153	0.00329	CcSEcCtD
Bosutinib—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00153	0.00328	CcSEcCtD
Bosutinib—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00153	0.00328	CcSEcCtD
Bosutinib—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00152	0.00327	CcSEcCtD
Bosutinib—Urethral disorder—Zoledronate—Paget's disease of bone	0.00152	0.00326	CcSEcCtD
Bosutinib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00152	0.00326	CcSEcCtD
Bosutinib—Back pain—Risedronate—Paget's disease of bone	0.0015	0.00323	CcSEcCtD
Bosutinib—Malnutrition—Pamidronate—Paget's disease of bone	0.00148	0.00317	CcSEcCtD
Bosutinib—Urticaria—Etidronic acid—Paget's disease of bone	0.00148	0.00317	CcSEcCtD
Bosutinib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00147	0.00315	CcSEcCtD
Bosutinib—Dysgeusia—Pamidronate—Paget's disease of bone	0.00145	0.00311	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00144	0.00309	CcSEcCtD
Bosutinib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00144	0.00309	CcSEcCtD
Bosutinib—Anaemia—Risedronate—Paget's disease of bone	0.00144	0.00309	CcSEcCtD
Bosutinib—Back pain—Pamidronate—Paget's disease of bone	0.00143	0.00307	CcSEcCtD
Bosutinib—Immune system disorder—Zoledronate—Paget's disease of bone	0.0014	0.00301	CcSEcCtD
Bosutinib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.0014	0.003	CcSEcCtD
Bosutinib—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00137	0.00294	CcSEcCtD
Bosutinib—Anaemia—Pamidronate—Paget's disease of bone	0.00137	0.00293	CcSEcCtD
Bosutinib—Cough—Risedronate—Paget's disease of bone	0.00136	0.00291	CcSEcCtD
Bosutinib—Pain—Alendronate—Paget's disease of bone	0.00135	0.0029	CcSEcCtD
Bosutinib—Malnutrition—Zoledronate—Paget's disease of bone	0.00135	0.0029	CcSEcCtD
Bosutinib—Malaise—Pamidronate—Paget's disease of bone	0.00133	0.00286	CcSEcCtD
Bosutinib—Chest pain—Risedronate—Paget's disease of bone	0.00132	0.00284	CcSEcCtD
Bosutinib—Myalgia—Risedronate—Paget's disease of bone	0.00132	0.00284	CcSEcCtD
Bosutinib—Arthralgia—Risedronate—Paget's disease of bone	0.00132	0.00284	CcSEcCtD
Bosutinib—Leukopenia—Pamidronate—Paget's disease of bone	0.00132	0.00284	CcSEcCtD
Bosutinib—Dysgeusia—Zoledronate—Paget's disease of bone	0.00132	0.00284	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00132	0.00282	CcSEcCtD
Bosutinib—Pruritus—Etidronic acid—Paget's disease of bone	0.00131	0.00282	CcSEcCtD
Bosutinib—Back pain—Zoledronate—Paget's disease of bone	0.00131	0.0028	CcSEcCtD
Bosutinib—Feeling abnormal—Alendronate—Paget's disease of bone	0.0013	0.0028	CcSEcCtD
Bosutinib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00129	0.00278	CcSEcCtD
Bosutinib—Cough—Pamidronate—Paget's disease of bone	0.00129	0.00277	CcSEcCtD
Bosutinib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00127	0.00273	CcSEcCtD
Bosutinib—Infection—Risedronate—Paget's disease of bone	0.00126	0.00271	CcSEcCtD
Bosutinib—Arthralgia—Pamidronate—Paget's disease of bone	0.00126	0.0027	CcSEcCtD
Bosutinib—Myalgia—Pamidronate—Paget's disease of bone	0.00126	0.0027	CcSEcCtD
Bosutinib—Urticaria—Alendronate—Paget's disease of bone	0.00126	0.0027	CcSEcCtD
Bosutinib—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00125	0.00269	CcSEcCtD
Bosutinib—Abdominal pain—Alendronate—Paget's disease of bone	0.00125	0.00268	CcSEcCtD
Bosutinib—Body temperature increased—Alendronate—Paget's disease of bone	0.00125	0.00268	CcSEcCtD
Bosutinib—Anaemia—Zoledronate—Paget's disease of bone	0.00125	0.00268	CcSEcCtD
Bosutinib—Nervous system disorder—Risedronate—Paget's disease of bone	0.00125	0.00267	CcSEcCtD
Bosutinib—Discomfort—Pamidronate—Paget's disease of bone	0.00124	0.00267	CcSEcCtD
Bosutinib—Skin disorder—Risedronate—Paget's disease of bone	0.00123	0.00265	CcSEcCtD
Bosutinib—Malaise—Zoledronate—Paget's disease of bone	0.00122	0.00261	CcSEcCtD
Bosutinib—Leukopenia—Zoledronate—Paget's disease of bone	0.00121	0.00259	CcSEcCtD
Bosutinib—Oedema—Pamidronate—Paget's disease of bone	0.00121	0.00259	CcSEcCtD
Bosutinib—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00121	0.00259	CcSEcCtD
Bosutinib—Infection—Pamidronate—Paget's disease of bone	0.0012	0.00257	CcSEcCtD
Bosutinib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00118	0.00254	CcSEcCtD
Bosutinib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00118	0.00254	CcSEcCtD
Bosutinib—Vomiting—Etidronic acid—Paget's disease of bone	0.00118	0.00253	CcSEcCtD
Bosutinib—Cough—Zoledronate—Paget's disease of bone	0.00118	0.00253	CcSEcCtD
Bosutinib—Rash—Etidronic acid—Paget's disease of bone	0.00117	0.00251	CcSEcCtD
Bosutinib—Dermatitis—Etidronic acid—Paget's disease of bone	0.00117	0.00251	CcSEcCtD
Bosutinib—Headache—Etidronic acid—Paget's disease of bone	0.00116	0.0025	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00116	0.00248	CcSEcCtD
Bosutinib—Myalgia—Zoledronate—Paget's disease of bone	0.00115	0.00247	CcSEcCtD
Bosutinib—Arthralgia—Zoledronate—Paget's disease of bone	0.00115	0.00247	CcSEcCtD
Bosutinib—Chest pain—Zoledronate—Paget's disease of bone	0.00115	0.00247	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00114	0.00245	CcSEcCtD
Bosutinib—Discomfort—Zoledronate—Paget's disease of bone	0.00114	0.00244	CcSEcCtD
Bosutinib—Asthenia—Alendronate—Paget's disease of bone	0.00114	0.00244	CcSEcCtD
Bosutinib—Dyspnoea—Risedronate—Paget's disease of bone	0.00113	0.00243	CcSEcCtD
Bosutinib—Pruritus—Alendronate—Paget's disease of bone	0.00112	0.0024	CcSEcCtD
Bosutinib—Nausea—Etidronic acid—Paget's disease of bone	0.0011	0.00237	CcSEcCtD
Bosutinib—Oedema—Zoledronate—Paget's disease of bone	0.0011	0.00237	CcSEcCtD
Bosutinib—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.0011	0.00237	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.0011	0.00236	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.0011	0.00235	CcSEcCtD
Bosutinib—Infection—Zoledronate—Paget's disease of bone	0.0011	0.00235	CcSEcCtD
Bosutinib—Fatigue—Risedronate—Paget's disease of bone	0.00109	0.00235	CcSEcCtD
Bosutinib—Pain—Risedronate—Paget's disease of bone	0.00109	0.00233	CcSEcCtD
Bosutinib—Diarrhoea—Alendronate—Paget's disease of bone	0.00108	0.00232	CcSEcCtD
Bosutinib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00108	0.00232	CcSEcCtD
Bosutinib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00108	0.00232	CcSEcCtD
Bosutinib—Dyspnoea—Pamidronate—Paget's disease of bone	0.00108	0.00231	CcSEcCtD
Bosutinib—Skin disorder—Zoledronate—Paget's disease of bone	0.00107	0.0023	CcSEcCtD
Bosutinib—Decreased appetite—Pamidronate—Paget's disease of bone	0.00105	0.00225	CcSEcCtD
Bosutinib—Dizziness—Alendronate—Paget's disease of bone	0.00105	0.00225	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00104	0.00224	CcSEcCtD
Bosutinib—Fatigue—Pamidronate—Paget's disease of bone	0.00104	0.00223	CcSEcCtD
Bosutinib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00104	0.00223	CcSEcCtD
Bosutinib—Pain—Pamidronate—Paget's disease of bone	0.00103	0.00221	CcSEcCtD
Bosutinib—Urticaria—Risedronate—Paget's disease of bone	0.00101	0.00216	CcSEcCtD
Bosutinib—Vomiting—Alendronate—Paget's disease of bone	0.00101	0.00216	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.001	0.00216	CcSEcCtD
Bosutinib—Abdominal pain—Risedronate—Paget's disease of bone	0.001	0.00215	CcSEcCtD
Bosutinib—Body temperature increased—Risedronate—Paget's disease of bone	0.001	0.00215	CcSEcCtD
Bosutinib—Rash—Alendronate—Paget's disease of bone	0.000998	0.00214	CcSEcCtD
Bosutinib—Dermatitis—Alendronate—Paget's disease of bone	0.000997	0.00214	CcSEcCtD
Bosutinib—Feeling abnormal—Pamidronate—Paget's disease of bone	0.000995	0.00213	CcSEcCtD
Bosutinib—Headache—Alendronate—Paget's disease of bone	0.000991	0.00213	CcSEcCtD
Bosutinib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000987	0.00212	CcSEcCtD
Bosutinib—Dyspnoea—Zoledronate—Paget's disease of bone	0.000983	0.00211	CcSEcCtD
Bosutinib—Decreased appetite—Zoledronate—Paget's disease of bone	0.000958	0.00206	CcSEcCtD
Bosutinib—Abdominal pain—Pamidronate—Paget's disease of bone	0.000954	0.00205	CcSEcCtD
Bosutinib—Body temperature increased—Pamidronate—Paget's disease of bone	0.000954	0.00205	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000952	0.00204	CcSEcCtD
Bosutinib—Fatigue—Zoledronate—Paget's disease of bone	0.000951	0.00204	CcSEcCtD
Bosutinib—Pain—Zoledronate—Paget's disease of bone	0.000943	0.00202	CcSEcCtD
Bosutinib—Nausea—Alendronate—Paget's disease of bone	0.00094	0.00202	CcSEcCtD
Bosutinib—Asthenia—Risedronate—Paget's disease of bone	0.000911	0.00195	CcSEcCtD
Bosutinib—Feeling abnormal—Zoledronate—Paget's disease of bone	0.000909	0.00195	CcSEcCtD
Bosutinib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000902	0.00193	CcSEcCtD
Bosutinib—Pruritus—Risedronate—Paget's disease of bone	0.000898	0.00193	CcSEcCtD
Bosutinib—Urticaria—Zoledronate—Paget's disease of bone	0.000876	0.00188	CcSEcCtD
Bosutinib—Abdominal pain—Zoledronate—Paget's disease of bone	0.000872	0.00187	CcSEcCtD
Bosutinib—Body temperature increased—Zoledronate—Paget's disease of bone	0.000872	0.00187	CcSEcCtD
Bosutinib—Diarrhoea—Risedronate—Paget's disease of bone	0.000869	0.00186	CcSEcCtD
Bosutinib—Asthenia—Pamidronate—Paget's disease of bone	0.000866	0.00186	CcSEcCtD
Bosutinib—Pruritus—Pamidronate—Paget's disease of bone	0.000854	0.00183	CcSEcCtD
Bosutinib—Dizziness—Risedronate—Paget's disease of bone	0.00084	0.0018	CcSEcCtD
Bosutinib—Diarrhoea—Pamidronate—Paget's disease of bone	0.000826	0.00177	CcSEcCtD
Bosutinib—Vomiting—Risedronate—Paget's disease of bone	0.000807	0.00173	CcSEcCtD
Bosutinib—Rash—Risedronate—Paget's disease of bone	0.000801	0.00172	CcSEcCtD
Bosutinib—Dermatitis—Risedronate—Paget's disease of bone	0.0008	0.00172	CcSEcCtD
Bosutinib—Dizziness—Pamidronate—Paget's disease of bone	0.000798	0.00171	CcSEcCtD
Bosutinib—Headache—Risedronate—Paget's disease of bone	0.000795	0.00171	CcSEcCtD
Bosutinib—Asthenia—Zoledronate—Paget's disease of bone	0.000791	0.0017	CcSEcCtD
Bosutinib—Pruritus—Zoledronate—Paget's disease of bone	0.00078	0.00167	CcSEcCtD
Bosutinib—Vomiting—Pamidronate—Paget's disease of bone	0.000767	0.00165	CcSEcCtD
Bosutinib—Rash—Pamidronate—Paget's disease of bone	0.000761	0.00163	CcSEcCtD
Bosutinib—Dermatitis—Pamidronate—Paget's disease of bone	0.00076	0.00163	CcSEcCtD
Bosutinib—Headache—Pamidronate—Paget's disease of bone	0.000756	0.00162	CcSEcCtD
Bosutinib—Diarrhoea—Zoledronate—Paget's disease of bone	0.000754	0.00162	CcSEcCtD
Bosutinib—Nausea—Risedronate—Paget's disease of bone	0.000754	0.00162	CcSEcCtD
Bosutinib—Dizziness—Zoledronate—Paget's disease of bone	0.000729	0.00156	CcSEcCtD
Bosutinib—Nausea—Pamidronate—Paget's disease of bone	0.000717	0.00154	CcSEcCtD
Bosutinib—Vomiting—Zoledronate—Paget's disease of bone	0.000701	0.0015	CcSEcCtD
Bosutinib—Rash—Zoledronate—Paget's disease of bone	0.000695	0.00149	CcSEcCtD
Bosutinib—Dermatitis—Zoledronate—Paget's disease of bone	0.000694	0.00149	CcSEcCtD
Bosutinib—Headache—Zoledronate—Paget's disease of bone	0.000691	0.00148	CcSEcCtD
Bosutinib—Nausea—Zoledronate—Paget's disease of bone	0.000655	0.00141	CcSEcCtD
Bosutinib—IKBKE—Immune System—SQSTM1—Paget's disease of bone	0.000194	0.000364	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—PML—Paget's disease of bone	0.000193	0.000361	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—INPP5D—Paget's disease of bone	0.000192	0.000359	CbGpPWpGaD
Bosutinib—SYK—Immune System—INPP5D—Paget's disease of bone	0.000189	0.000355	CbGpPWpGaD
Bosutinib—TBK1—Immune System—NUP205—Paget's disease of bone	0.000189	0.000354	CbGpPWpGaD
Bosutinib—ERBB3—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000189	0.000354	CbGpPWpGaD
Bosutinib—LCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000188	0.000352	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—VCP—Paget's disease of bone	0.000188	0.000352	CbGpPWpGaD
Bosutinib—CSK—Immune System—PML—Paget's disease of bone	0.000186	0.000349	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—INPP5D—Paget's disease of bone	0.000186	0.000348	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—NUP205—Paget's disease of bone	0.000185	0.000347	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—VCP—Paget's disease of bone	0.000185	0.000346	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—VCP—Paget's disease of bone	0.000185	0.000346	CbGpPWpGaD
Bosutinib—ERBB4—Disease—VCP—Paget's disease of bone	0.000184	0.000345	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—NUP205—Paget's disease of bone	0.000181	0.000339	CbGpPWpGaD
Bosutinib—CSK—Immune System—INPP5D—Paget's disease of bone	0.00018	0.000336	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—VCP—Paget's disease of bone	0.000178	0.000334	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling by GPCR—CALCA—Paget's disease of bone	0.000177	0.000332	CbGpPWpGaD
Bosutinib—BTK—Immune System—NUP205—Paget's disease of bone	0.000176	0.00033	CbGpPWpGaD
Bosutinib—EGFR—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000172	0.000322	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00017	0.000319	CbGpPWpGaD
Bosutinib—SYK—Immune System—SQSTM1—Paget's disease of bone	0.00017	0.000318	CbGpPWpGaD
Bosutinib—LCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000169	0.000316	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—NUP205—Paget's disease of bone	0.000168	0.000315	CbGpPWpGaD
Bosutinib—TBK1—Immune System—PML—Paget's disease of bone	0.000167	0.000313	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—SQSTM1—Paget's disease of bone	0.000167	0.000312	CbGpPWpGaD
Bosutinib—LCK—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000166	0.00031	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000166	0.00031	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—CALCA—Paget's disease of bone	0.000166	0.00031	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—PML—Paget's disease of bone	0.000164	0.000307	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—NUP205—Paget's disease of bone	0.000163	0.000305	CbGpPWpGaD
Bosutinib—ERBB3—Disease—VCP—Paget's disease of bone	0.000162	0.000304	CbGpPWpGaD
Bosutinib—HCK—Immune System—NUP205—Paget's disease of bone	0.000162	0.000303	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000162	0.000303	CbGpPWpGaD
Bosutinib—TBK1—Immune System—INPP5D—Paget's disease of bone	0.000161	0.000302	CbGpPWpGaD
Bosutinib—CSK—Immune System—SQSTM1—Paget's disease of bone	0.000161	0.000302	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—PML—Paget's disease of bone	0.00016	0.0003	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—INPP5D—Paget's disease of bone	0.000158	0.000296	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—CALCA—Paget's disease of bone	0.000157	0.000294	CbGpPWpGaD
Bosutinib—BTK—Immune System—PML—Paget's disease of bone	0.000156	0.000292	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—INPP5D—Paget's disease of bone	0.000154	0.000289	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000154	0.000289	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—NUP205—Paget's disease of bone	0.000152	0.000285	CbGpPWpGaD
Bosutinib—BTK—Immune System—INPP5D—Paget's disease of bone	0.00015	0.000281	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—NUP205—Paget's disease of bone	0.00015	0.000281	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—CALCA—Paget's disease of bone	0.00015	0.00028	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—CALCA—Paget's disease of bone	0.000149	0.00028	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—CALCA—Paget's disease of bone	0.000149	0.00028	CbGpPWpGaD
Bosutinib—HCK—Disease—NUP205—Paget's disease of bone	0.000149	0.00028	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—VCP—Paget's disease of bone	0.000149	0.000279	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—PML—Paget's disease of bone	0.000149	0.000279	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000148	0.000277	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000148	0.000277	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000147	0.000275	CbGpPWpGaD
Bosutinib—BLK—Immune System—NUP205—Paget's disease of bone	0.000147	0.000274	CbGpPWpGaD
Bosutinib—FGR—Immune System—NUP205—Paget's disease of bone	0.000146	0.000273	CbGpPWpGaD
Bosutinib—TBK1—Immune System—SQSTM1—Paget's disease of bone	0.000144	0.000271	CbGpPWpGaD
Bosutinib—CSK—Disease—CALCA—Paget's disease of bone	0.000144	0.00027	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—INPP5D—Paget's disease of bone	0.000144	0.000269	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—CALCA—Paget's disease of bone	0.000144	0.000269	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—INPP5D—Paget's disease of bone	0.000143	0.000268	CbGpPWpGaD
Bosutinib—HCK—Immune System—PML—Paget's disease of bone	0.000143	0.000268	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—INPP5D—Paget's disease of bone	0.000142	0.000266	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—SQSTM1—Paget's disease of bone	0.000142	0.000266	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—INPP5D—Paget's disease of bone	0.000141	0.000264	CbGpPWpGaD
Bosutinib—ERBB4—Disease—NUP205—Paget's disease of bone	0.000141	0.000263	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000139	0.00026	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—SQSTM1—Paget's disease of bone	0.000138	0.000259	CbGpPWpGaD
Bosutinib—HCK—Immune System—INPP5D—Paget's disease of bone	0.000138	0.000258	CbGpPWpGaD
Bosutinib—BTK—Immune System—SQSTM1—Paget's disease of bone	0.000135	0.000252	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—PML—Paget's disease of bone	0.000135	0.000252	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—NUP205—Paget's disease of bone	0.000134	0.000251	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—PML—Paget's disease of bone	0.000133	0.000248	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—INPP5D—Paget's disease of bone	0.00013	0.000243	CbGpPWpGaD
Bosutinib—BLK—Immune System—PML—Paget's disease of bone	0.000129	0.000243	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000129	0.000242	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000129	0.000242	CbGpPWpGaD
Bosutinib—FGR—Immune System—PML—Paget's disease of bone	0.000129	0.000242	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—VCP—Paget's disease of bone	0.000129	0.000241	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—SQSTM1—Paget's disease of bone	0.000129	0.000241	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—INPP5D—Paget's disease of bone	0.000128	0.00024	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—VCP—Paget's disease of bone	0.000127	0.000238	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000126	0.000236	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—CALCA—Paget's disease of bone	0.000125	0.000235	CbGpPWpGaD
Bosutinib—BLK—Immune System—INPP5D—Paget's disease of bone	0.000125	0.000234	CbGpPWpGaD
Bosutinib—FGR—Immune System—INPP5D—Paget's disease of bone	0.000125	0.000233	CbGpPWpGaD
Bosutinib—ERBB3—Disease—NUP205—Paget's disease of bone	0.000124	0.000232	CbGpPWpGaD
Bosutinib—HCK—Immune System—SQSTM1—Paget's disease of bone	0.000124	0.000231	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000124	0.000231	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—VCP—Paget's disease of bone	0.000122	0.000229	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000122	0.000228	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—CALCA—Paget's disease of bone	0.000121	0.000226	CbGpPWpGaD
Bosutinib—PTK2—Immune System—NUP205—Paget's disease of bone	0.00012	0.000224	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—PML—Paget's disease of bone	0.000119	0.000222	CbGpPWpGaD
Bosutinib—YES1—Immune System—NUP205—Paget's disease of bone	0.000118	0.000221	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—VCP—Paget's disease of bone	0.000118	0.000221	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—VCP—Paget's disease of bone	0.000118	0.000221	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—CALCA—Paget's disease of bone	0.000117	0.00022	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—INPP5D—Paget's disease of bone	0.000117	0.000219	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—SQSTM1—Paget's disease of bone	0.000116	0.000218	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—SQSTM1—Paget's disease of bone	0.000115	0.000215	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—INPP5D—Paget's disease of bone	0.000114	0.000214	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—VCP—Paget's disease of bone	0.000114	0.000213	CbGpPWpGaD
Bosutinib—BLK—Immune System—SQSTM1—Paget's disease of bone	0.000112	0.00021	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—NUP205—Paget's disease of bone	0.000112	0.000209	CbGpPWpGaD
Bosutinib—FGR—Immune System—SQSTM1—Paget's disease of bone	0.000112	0.000209	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—VCP—Paget's disease of bone	0.000111	0.000208	CbGpPWpGaD
Bosutinib—HCK—Disease—CALCA—Paget's disease of bone	0.000111	0.000208	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00011	0.000206	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—VCP—Paget's disease of bone	0.000108	0.000203	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000108	0.000202	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000108	0.000202	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—CALCA—Paget's disease of bone	0.000107	0.0002	CbGpPWpGaD
Bosutinib—PTK2—Immune System—PML—Paget's disease of bone	0.000106	0.000198	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—NUP205—Paget's disease of bone	0.000105	0.000197	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000105	0.000197	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—CALCA—Paget's disease of bone	0.000105	0.000196	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—CALCA—Paget's disease of bone	0.000105	0.000196	CbGpPWpGaD
Bosutinib—FYN—Disease—VCP—Paget's disease of bone	0.000105	0.000196	CbGpPWpGaD
Bosutinib—ERBB4—Disease—CALCA—Paget's disease of bone	0.000104	0.000195	CbGpPWpGaD
Bosutinib—YES1—Immune System—PML—Paget's disease of bone	0.000104	0.000195	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000104	0.000195	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—VCP—Paget's disease of bone	0.000104	0.000195	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—INPP5D—Paget's disease of bone	0.000104	0.000194	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—SQSTM1—Paget's disease of bone	0.000103	0.000192	CbGpPWpGaD
Bosutinib—PTK2—Immune System—INPP5D—Paget's disease of bone	0.000102	0.000191	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000101	0.00019	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—CALCA—Paget's disease of bone	0.000101	0.000189	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VCP—Paget's disease of bone	0.000101	0.000189	CbGpPWpGaD
Bosutinib—YES1—Immune System—INPP5D—Paget's disease of bone	0.000101	0.000188	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VCP—Paget's disease of bone	9.97e-05	0.000187	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—PML—Paget's disease of bone	9.88e-05	0.000185	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—INPP5D—Paget's disease of bone	9.53e-05	0.000179	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VCP—Paget's disease of bone	9.46e-05	0.000177	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—PML—Paget's disease of bone	9.3e-05	0.000174	CbGpPWpGaD
Bosutinib—ERBB3—Disease—CALCA—Paget's disease of bone	9.2e-05	0.000172	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—NUP205—Paget's disease of bone	9.2e-05	0.000172	CbGpPWpGaD
Bosutinib—PTK2—Immune System—SQSTM1—Paget's disease of bone	9.14e-05	0.000171	CbGpPWpGaD
Bosutinib—EGFR—Disease—VCP—Paget's disease of bone	9.03e-05	0.000169	CbGpPWpGaD
Bosutinib—YES1—Immune System—SQSTM1—Paget's disease of bone	9.01e-05	0.000169	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—NUP205—Paget's disease of bone	8.98e-05	0.000168	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—INPP5D—Paget's disease of bone	8.98e-05	0.000168	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—INPP5D—Paget's disease of bone	8.97e-05	0.000168	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VCP—Paget's disease of bone	8.9e-05	0.000167	CbGpPWpGaD
Bosutinib—LYN—Immune System—NUP205—Paget's disease of bone	8.79e-05	0.000165	CbGpPWpGaD
Bosutinib—ABL1—Immune System—NUP205—Paget's disease of bone	8.75e-05	0.000164	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—SQSTM1—Paget's disease of bone	8.71e-05	0.000163	CbGpPWpGaD
Bosutinib—LCK—Disease—VCP—Paget's disease of bone	8.7e-05	0.000163	CbGpPWpGaD
Bosutinib—FYN—Immune System—NUP205—Paget's disease of bone	8.65e-05	0.000162	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—NUP205—Paget's disease of bone	8.61e-05	0.000161	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—SQSTM1—Paget's disease of bone	8.55e-05	0.00016	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—NUP205—Paget's disease of bone	8.49e-05	0.000159	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—CALCA—Paget's disease of bone	8.46e-05	0.000158	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—NUP205—Paget's disease of bone	8.29e-05	0.000155	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—PML—Paget's disease of bone	8.13e-05	0.000152	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—SQSTM1—Paget's disease of bone	8.05e-05	0.000151	CbGpPWpGaD
Bosutinib—FYN—Disease—NUP205—Paget's disease of bone	7.99e-05	0.00015	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—NUP205—Paget's disease of bone	7.95e-05	0.000149	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—PML—Paget's disease of bone	7.93e-05	0.000149	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—INPP5D—Paget's disease of bone	7.84e-05	0.000147	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VCP—Paget's disease of bone	7.78e-05	0.000146	CbGpPWpGaD
Bosutinib—LYN—Immune System—PML—Paget's disease of bone	7.77e-05	0.000145	CbGpPWpGaD
Bosutinib—ABL1—Immune System—PML—Paget's disease of bone	7.73e-05	0.000145	CbGpPWpGaD
Bosutinib—SRC—Disease—VCP—Paget's disease of bone	7.7e-05	0.000144	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—INPP5D—Paget's disease of bone	7.65e-05	0.000143	CbGpPWpGaD
Bosutinib—FYN—Immune System—PML—Paget's disease of bone	7.65e-05	0.000143	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—PML—Paget's disease of bone	7.61e-05	0.000142	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VCP—Paget's disease of bone	7.59e-05	0.000142	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—SQSTM1—Paget's disease of bone	7.53e-05	0.000141	CbGpPWpGaD
Bosutinib—LYN—Immune System—INPP5D—Paget's disease of bone	7.49e-05	0.00014	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NUP205—Paget's disease of bone	7.48e-05	0.00014	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—CALCA—Paget's disease of bone	7.47e-05	0.00014	CbGpPWpGaD
Bosutinib—ABL1—Immune System—INPP5D—Paget's disease of bone	7.46e-05	0.00014	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VCP—Paget's disease of bone	7.44e-05	0.000139	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—SQSTM1—Paget's disease of bone	7.42e-05	0.000139	CbGpPWpGaD
Bosutinib—FYN—Immune System—INPP5D—Paget's disease of bone	7.38e-05	0.000138	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—INPP5D—Paget's disease of bone	7.34e-05	0.000137	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VCP—Paget's disease of bone	7.32e-05	0.000137	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CALCA—Paget's disease of bone	7.31e-05	0.000137	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VCP—Paget's disease of bone	7.28e-05	0.000136	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CALCA—Paget's disease of bone	7.2e-05	0.000135	CbGpPWpGaD
Bosutinib—LCK—Immune System—NUP205—Paget's disease of bone	7.2e-05	0.000135	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—SQSTM1—Paget's disease of bone	7.15e-05	0.000134	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—SQSTM1—Paget's disease of bone	7.03e-05	0.000132	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—CALCA—Paget's disease of bone	6.99e-05	0.000131	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CALCA—Paget's disease of bone	6.94e-05	0.00013	CbGpPWpGaD
Bosutinib—EGFR—Disease—NUP205—Paget's disease of bone	6.9e-05	0.000129	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—SQSTM1—Paget's disease of bone	6.88e-05	0.000129	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—SQSTM1—Paget's disease of bone	6.88e-05	0.000129	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—SQSTM1—Paget's disease of bone	6.86e-05	0.000129	CbGpPWpGaD
Bosutinib—LYN—Immune System—SQSTM1—Paget's disease of bone	6.72e-05	0.000126	CbGpPWpGaD
Bosutinib—ABL1—Immune System—SQSTM1—Paget's disease of bone	6.69e-05	0.000125	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CALCA—Paget's disease of bone	6.69e-05	0.000125	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CALCA—Paget's disease of bone	6.69e-05	0.000125	CbGpPWpGaD
Bosutinib—LCK—Disease—NUP205—Paget's disease of bone	6.65e-05	0.000125	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SQSTM1—Paget's disease of bone	6.64e-05	0.000124	CbGpPWpGaD
Bosutinib—FYN—Immune System—SQSTM1—Paget's disease of bone	6.61e-05	0.000124	CbGpPWpGaD
Bosutinib—EGFR—Immune System—PML—Paget's disease of bone	6.61e-05	0.000124	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—SQSTM1—Paget's disease of bone	6.58e-05	0.000123	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CALCA—Paget's disease of bone	6.44e-05	0.000121	CbGpPWpGaD
Bosutinib—SRC—Immune System—NUP205—Paget's disease of bone	6.38e-05	0.000119	CbGpPWpGaD
Bosutinib—EGFR—Immune System—INPP5D—Paget's disease of bone	6.37e-05	0.000119	CbGpPWpGaD
Bosutinib—LCK—Immune System—PML—Paget's disease of bone	6.37e-05	0.000119	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VCP—Paget's disease of bone	6.32e-05	0.000118	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CALCA—Paget's disease of bone	6.3e-05	0.000118	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	6.23e-05	0.000117	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CALCA—Paget's disease of bone	6.15e-05	0.000115	CbGpPWpGaD
Bosutinib—LCK—Immune System—INPP5D—Paget's disease of bone	6.14e-05	0.000115	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VCP—Paget's disease of bone	6.09e-05	0.000114	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CALCA—Paget's disease of bone	6.07e-05	0.000114	CbGpPWpGaD
Bosutinib—FYN—Disease—CALCA—Paget's disease of bone	5.93e-05	0.000111	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SQSTM1—Paget's disease of bone	5.91e-05	0.000111	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CALCA—Paget's disease of bone	5.9e-05	0.00011	CbGpPWpGaD
Bosutinib—SRC—Disease—NUP205—Paget's disease of bone	5.89e-05	0.00011	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SQSTM1—Paget's disease of bone	5.83e-05	0.000109	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CALCA—Paget's disease of bone	5.74e-05	0.000107	CbGpPWpGaD
Bosutinib—EGFR—Immune System—SQSTM1—Paget's disease of bone	5.71e-05	0.000107	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CALCA—Paget's disease of bone	5.66e-05	0.000106	CbGpPWpGaD
Bosutinib—SRC—Immune System—PML—Paget's disease of bone	5.64e-05	0.000106	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SQSTM1—Paget's disease of bone	5.53e-05	0.000103	CbGpPWpGaD
Bosutinib—LCK—Immune System—SQSTM1—Paget's disease of bone	5.51e-05	0.000103	CbGpPWpGaD
Bosutinib—SRC—Immune System—INPP5D—Paget's disease of bone	5.44e-05	0.000102	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VCP—Paget's disease of bone	5.4e-05	0.000101	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CALCA—Paget's disease of bone	5.37e-05	0.0001	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SQSTM1—Paget's disease of bone	5.2e-05	9.74e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CALCA—Paget's disease of bone	5.12e-05	9.59e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CALCA—Paget's disease of bone	5.05e-05	9.46e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CALCA—Paget's disease of bone	4.94e-05	9.25e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—SQSTM1—Paget's disease of bone	4.87e-05	9.13e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SQSTM1—Paget's disease of bone	4.55e-05	8.51e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SQSTM1—Paget's disease of bone	4.44e-05	8.31e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CALCA—Paget's disease of bone	4.41e-05	8.27e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CALCA—Paget's disease of bone	4.37e-05	8.19e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SQSTM1—Paget's disease of bone	4.34e-05	8.13e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CALCA—Paget's disease of bone	4.31e-05	8.07e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SQSTM1—Paget's disease of bone	4.28e-05	8.01e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SQSTM1—Paget's disease of bone	4.25e-05	7.97e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CALCA—Paget's disease of bone	4.22e-05	7.9e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CALCA—Paget's disease of bone	4.15e-05	7.78e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CALCA—Paget's disease of bone	4.13e-05	7.74e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SQSTM1—Paget's disease of bone	3.69e-05	6.92e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CALCA—Paget's disease of bone	3.59e-05	6.72e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SQSTM1—Paget's disease of bone	3.56e-05	6.67e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CALCA—Paget's disease of bone	3.46e-05	6.48e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SQSTM1—Paget's disease of bone	3.15e-05	5.9e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CALCA—Paget's disease of bone	3.06e-05	5.73e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NUP205—Paget's disease of bone	2.92e-05	5.46e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—INPP5D—Paget's disease of bone	2.49e-05	4.66e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	1.8e-05	3.37e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	1.53e-05	2.87e-05	CbGpPWpGaD
